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Abstract 
Introduction: Critical illness is associated with muscle loss, weakness and poor recovery. The 
impact illness and ensuing metabolic response has on obese patients is not known. 
Objectives were to test if obese patients lose less muscle depth compared to non-obese; if a 
reduction in muscle depth was associated with reduced strength and recovery; and to 
assess the feasibility of these methods with a range of Body Mass Index’s (BMI). 
Methods: Prospective observational pilot study of muscle depth in critically ill patients 
categorised by BMI. Muscle depth changes were assessed by ultrasound on study days 1, 3, 
5, 7, 12 and 14. Strength was measured via handgrip dynamometry and Medical Research 
Council (MRC) sum score at waking and Intensive Care Unit (ICU) discharge. Level of 
dependency was measured with the Barthel index. 
Results: 44 critically ill patients - 17 with normal BMI, 10 were overweight and 17 were 
obese. The 3 groups did not differ in baseline characteristics, except obese patients had 
significantly greater initial muscle depth.  Muscle depth loss was similar between the BMI 
groups at each of the time points. Handgrip and MRC sum score were only possible in a 
small number of patients due to reduced alertness and weakness. The majority were 
deemed fully dependent based on the Barthel index.  
Conclusions: Obese patients lost muscle depth in a comparable manner to non-obese 
patients, suggesting BMI may not prevent muscle depth loss. It was not possible to 
determine the effect on strength since clinical patient clinical condition precluded reliable 
measurements.  
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Introduction 
Critical illness is associated with hypermetabolism and catabolism which results in a 
dramatic loss of muscle mass (1; 2). Patients who are mechanically ventilated for longer than 
seven days frequently experience muscle wasting syndromes or profound weakness 
(referred to as intensive care unit (ICU) acquired weakness) (3; 4).  This is unequivocally 
associated with decreased survival, increased rates of infections, longer hospital stays and 
delayed recovery, and increase healthcare costs (5; 6).  
While many different, potentially interacting pathophysiological mechanisms have been 
proposed for ICU acquired weakness (7) no previous work explored the possible role of 
patients body composition or body mass index (BMI). The prevalence of obesity is increasing 
in ICU with large retrospective databases suggesting prevalence rates of 26-31% (8; 9).  
There is a lack of research detailing the nutritional and metabolic processes seen in obese 
critically ill patients. It is not clear what impact critical illness and the ensuing metabolic 
response has on obese patients and how this compares to non-obese patients. For example, 
patients with obesity maybe able to metabolise their excess adipose stores as the dominant 
fuel source and preserve muscle mass (10; 11; 12). One study of only 17 patients (7 obese) 
investigated if the metabolic response to trauma is different between obese and non-obese 
critically ill patients. Obese patients experienced increased nitrogen losses and reduced 
protein synthesis compared to the non-obese patients (13), suggesting that critically ill obese 
patients may lose the ability to conserve protein stores.  
Our study objectives were to: 1) test if obese patients lose less muscle depth compared to 
non-obese; 2) detect if a reduction in muscle depth was associated with reduced muscle 
strength and delayed functional recovery; and 3) as a pilot study, to assess the feasibility of 
performing these methods in patients with a range of BMI’s in order to inform a larger trial. 
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Materials and methods  
Study design 
This was a pilot feasibility, prospective observational study of critically ill patients over a one 
-year period (2010-2011). Patients were recruited from the general ICU’s in three tertiary UK 
teaching hospitals. Ethical approval was gained from the North West London Research 
Ethics Committee (NRES reference: 10/H0722/40). Written informed consent was obtained 
from patients or agreement sought from their designated representative, with retrospective 
patient consent obtained when full mental capacity was re-gained.  
Inclusion criteria were: older than 18 years, BMI more than 19kg/m 2, expected to be 
mechanically ventilated for longer than 48 hours, and being artificially fed. Pregnant 
patients were excluded. 
Patients were entered into the trial within 72 hours of ICU admission. Baseline 
demographics included admission reason / diagnosis, number of comorbidities (14), severity 
of illness defined by Acute Physiology And Chronic Health Evaluation score (APACHE II), and 
anthropometric measurements (weight, height and BMI). Data on mortality, ICU length of 
stay and days on mechanical ventilation were collected on conclusion of the study. 
Muscle depth 
Peripheral muscle depth changes at three sites (bicep, forearm and thigh) were assessed by 
ultrasound in every participant on study days 1, 3, 5, 7, 12 and 14  to detect muscle depth 
change over time according to protocols described previously (15; 16; 17). Three measurements 
were performed at each site and the mean calculated (16). For each patient, all 
measurements were performed by the same investigator. Standardised training protocols 
were followed.  
Physical Assessment: 
Two measures of strength were used: hand grip strength and the Medical Research Council 
(MRC) sum score for muscle power (3). These were measured at waking (sedation off and 
patient alert) and ICU discharge. To assess if the patient was awake enough to participate, a 
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four battery test was undertaken asking the following: open your eyes, follow my finger, 
stick your tongue out, and squeeze my hand.  
The MRC sum score was carried out on six different bilateral muscle groups: shoulder 
abduction, elbow flexion, wrist extension, hip flexion, knee extension and foot dorsiflexion. 
Strength in each muscle group was scored according to the six-point MRC system, in which a 
score of 0 was no contraction, 1 was a flicker of contraction, 2 was active movement with 
gravity eliminated, 3 was active movement against gravity, 4 was active movement against 
gravity and resistance and 5 was normal power. The maximum score is 60. A score below 48 
was used as a cut off to indicate ICU acquired weakness or muscle wasting (18). Two 
investigators (ES and LW) performed the MRC assessment after training from an 
experienced physiotherapist.  
Handgrip strength was measured to detect changes in lower arm and hand strength of the 
dominant hand using a hydraulic handgrip dynamometer (JAMAR, Lafayette Instruments 
Lafayette, USA). The patient was positioned in a sitting position with elbow flexion of 90 
degrees. An average of the three readings was used. A strength value below 11kg in males 
and 7kg in females corresponds with ICU acquired weakness or muscle wasting (19).  
The Barthel index was undertaken to assess the ability to undertake activities of daily living. 
It measures the capacity to perform ten basic activities and gives a quantitative estimate of 
the patient’s level of dependency and range from 0 (totally dependent) to 100 (totally 
independent). It has been used to assess functional recovery following critical illness (20; 21). 
Nutritional intake 
Patients were fed according to the units’ feeding protocol which stated that the enteral 
route should be the first choice, and nutrition should be commenced within 48 hours of 
admission. If enteral nutrition failed or was contraindicated, parenteral nutrition was 
commenced. The treating dietitian set the energy and protein targets. Energy requirements 
were calculated using Schofield equation adding factors for stress and activity to make it 
clinically relevant (22) or the Penn State Equations (23; 24) (currently recommended as the most 
accurate way to predict energy requirements for both obese and non-obese critically ill 
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patients) (25; 26). We had no access to indirect calorimetry. Protein requirements were 
calculated as 1.2-1.3g/kg actual body weight for normal weight patients (27; 28), 0.8-1.2g/kg 
actual body weight for obese (27) and adjusted to reflect clinical parameters such as renal 
and liver impairment, filtration and excess losses. Nutritional intake data were collected on 
a daily basis for the days that the patient remained in the study. For the analysis, the energy 
and protein prescription and received are expressed as Kcal/kg and gram/kg, respectively. 
This is the overall intake divided by body weight. This allows for direct comparison with 
other studies.  
Anthropometric measurements 
BMI was calculated using the most recent accurate body weight and height obtained from 
the patient’s medical notes. If unavailable, the patient was either weighed or estimated on 
the ICU bed, or weights sought from family members. When height was not available it was 
estimated from ulnar length measurement, taken between the point of the acromion and 
the ulnar styloid. This value was then converted into an estimated height (29)  
Statistical analysis 
Descriptive statistics are presented as median and inter-quartile range, or mean and 
standard deviation. Patients were categorised into three independent groups according to 
BMI: 
 Group 1 (Normal weight) BMI 19-24.9kg/m2 
 Group 2 (Overweight) BMI 25-29.9kg/m2 
 Group 3 (Obese) BMI ≥ 30kg/m2 
Comparisons between these groups were made using t-tests or Mann Whitney tests. 
Missing data was assumed to be missing at random. Missing day 7 values for the primary 
outcome were imputed by carrying forward day 5 values.  
Regression analysis was undertaken to quantify the association between muscle loss (loss as 
% from initial at day 7) and the following variables; baseline BMI, age, gender, 
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comorbidities, APACHE II and thickest muscle depth. Results are presented as coefficients, 
p-value and 95% confidence intervals. All statistical analyses were performed using Stata 13 
(Statcorp LP, USA). The statistical significance was defined at the 5% level.  
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Results 
Baseline characteristics are shown in Table 1. Figure 1 presents the patient flow diagram. 
Thirty-three (75%) patients were male, median age was 58 years and admission APACHE II 
score was 20. There were no differences in baseline characteristics on admission. Six (14%) 
patients were recruited within 24 hours of admission, 50% (22/44) within 48 hours and 36% 
(16/44) within 72 hours of admission to ICU.  
There was considerable loss to follow up observed in all three groups (Figure 1). From day 3 
there was missing data (as unable to perform tests due to clinical reasons) and most 
patients had been discharged or had died by day 12. For this reason, no results are 
presented for day 14 as only a total of 7/44 remained in the ICU.  
The obese group had statistically significantly greater initial combined muscle depth 
compared to the normal weight group, with an average of 3cm greater muscle depth (Table 
2). No significant difference in the combined muscle depth loss expressed as cm loss or 
percentage loss between the groups was seen over day five, seven or twelve.  
Table 1 in supplementary information reports the loss for each site (bicep, forearm and 
thigh). Obese patients had significantly more thigh depth compared to the non-obese 
patients (0.05). The percentage loss from initial over day 3, 5, 7 and 12 for each site was not 
different between the groups. The normal patients lost significantly more muscle depth in 
biceps compared to thighs at day 5 (p=0.003). However, this upper and lower limb 
difference was not observed in the other groups. Regression analysis of the relationship 
between day seven percentage loss and various independent variables (Table 3) found only 
gender was significant. When explored further (Supplementary information Table 2), 
women had significantly less initial muscle depth and lost significantly more at day 7 
compared to men.  
Nutritional data are shown in Table 3 in the supplementary information. The majority of 
patients (84%) were fed via the enteral route, the rest receiving parenteral nutrition, a 
combination of enteral and parenteral or oral nutrition. The mean energy prescription was 
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significantly less for the obese group compared to the other groups. Irrespective of BMI 
group, all patients received inadequate energy and protein as compared with their nutrition 
prescription. 
Functional recovery was difficult to assess with an inability of the patient to perform the 
tasks due to lack of alertness, weakness and poly-trauma. Due to the small numbers no 
analysis was reported. It was only possible to undertake the MRC sum score and handgrip 
strength tests in 12/44 patients (27%; normal weight = 4/17; overweight = 2/10; obese = 
6/17). The majority of patients were deemed fully dependent with the Barthel Index at days 
1 (98%), 3 (90%) and 7 (85%), with only 4 patients out of 27 gaining a score greater than 5 at 
day 7 of ICU admission.  
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Discussion 
To our knowledge this is the first study to investigate if muscle depth loss observed during 
critical illness differs between obese, overweight and normal weight patients using a muscle 
ultrasound technique. The muscle depth loss was comparable and not statistically different 
between the BMI groups at each of the time points. Increased muscle breakdown in obese 
patients was seen in the Jeevanadam et al study (13), although patients were not fed for 
the duration of this study and this may have influenced the rate of muscle breakdown. 
Direct comparisons cannot be made, as that study used the more precise method of whole 
body turnover to determine muscle loss compared to the ultrasound technique in our study.  
A trial using ultrasound muscle depth to measure muscle wasting in general ICU patients (16) 
found a decrease of 1.6% per day over seven days and those with the greatest amount of 
muscle at the start lost significantly more muscle. This was not observed in our study, where 
women had less muscle to start and lost significantly more. Low admission muscle mass has 
been shown to be a risk factor for mortality in critically ill patients (30). Campbell et al (15) 
studied nine patients with multi-organ failure (MOF) finding a decrease in muscle depth of 
6% per day. The muscle loss was considerably higher than the current study and that of Reid 
et al (16). This could be explained by illness severity, although Campbell provided no APACHE 
II or organ failure scores. One can only make assumptions based on the fact that they all had 
MOF.  
The idea that there is a relationship between the degree of organ failure and rates of muscle 
loss is developed further in the largest published muscle ultrasound study of ICU patients 
(31). Muscle mass decreased significantly at day 7 and was significantly greater in patients 
who experienced multi-organ failure by day 7 (losing 15.7%) compared with 3% loss with 
single organ failure. Our findings were comparable with that of the MOF patients.   
We presented our muscle depth loss as a combined score of three sites, and this may give 
the impression that all muscle groups waste at the same rate. This may not be the case. The 
different quadriceps muscles have been shown to waste at differing rates (32) and the 
diaphragmatic muscles wasted faster than quadriceps (33). In a study that used limb 
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circumference, muscle atrophy was observed more in the lower limbs compared with upper 
limbs (34). Although this method has been found to be inferior compared to USS in a recent 
systematic review (35). When we examined loss at each site individually the opposite was 
found with the normal weight patients experiencing a larger proportionate loss in the biceps 
compared to thighs. There was no difference between the groups in terms of wasting seen 
in at each of the three sites. This warrants further investigation in larger patient numbers.  
The USS technique was both feasible and a time efficient tool for use at the bedside in a 
range of BMI categories. It was not possible to undertake measures on nine occasions due 
to a variety of reasons, including the patient being too agitated, spastic flexion in the legs, 
skin breakdown, dressings, peripheral cannula and limbs in casts. There was no difference 
between the groups for reasons that the measures could not be performed. It was more 
difficult to obtain accurate images in the obese patients but by increasing the scanning 
depth it was possible in all patients.  
Due to low numbers able to undertake the functional recovery measures, the results are of 
limited value. Despite the MRC score being advocated as a predictor of ICU acquired 
weakness (18), there are limitations to its clinical usefulness (36). As in other trials a significant 
proportion of patients in our study were unable to perform the test (36; 37). The same was 
observed with the hand grip test, where many were too weak to even lift the tool. The 
Barthel score did not appear to be sensitive enough to detect subtle changes in recovery for 
this group of patients whilst they were in ICU. From our experience we recommend that the 
use of the MRC score and grip strength are clinically limited in the ICU and are best used 
once the patient has left the ICU.  
The majority of patients were enterally fed, which can be challenging to deliver (38). 
Common reasons for inadequate delivery are gastrointestinal intolerance and fasting for a 
variety of ICU related procedures. The poor nutritional delivery in our study may have 
influenced the rates of muscle depth lost, although we didn’t set out to measure this. In a 
previous study (16) where energy targets were determined by indirect calorimeter, achieving 
energy balance made no difference to muscle depth loss. Our findings and work of others 
(13) do not support the notion that obese patients are able to metabolise their excess fat 
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stores and preserve muscle mass. Therefore, based on our pilot study findings the practice 
of underfeeding obese critically ill patients warrants further investigation.  
Whilst the study participants are broadly representative of the general ICU population they 
were recruited from, it is not possible to make any concrete inferences about the 
generalizability of the results due to the small sample size. A larger study with more power 
is needed.  
Limitations 
As it was a feasibility pilot study no power calculation was undertaken, and the numbers 
recruited were small. We experienced considerable loss to follow up due to relatively short 
ICU stays whereas we had intended to follow patients for 14 days. The high attrition rate 
limits the validity and reliability of our results. To facilitate recruitment, patients could be 
recruited up to day three of admission to ICU, with the majority being recruited on day two. 
Substantial muscle loss can occur between day one and three, especially in those in multiple 
organ failure (31). In our study the majority were not recruited on day one so considerable 
muscle loss may already have occurred before our baseline measurements were taken. As 
such our results may under-estimation of the amount and rate of muscle depth loss during 
the ICU admission. As seen in the Puthecheary study (31), muscle wasting is significantly 
influenced by the level of organ failure. We did not collect data on numbers of organs 
failing, which would have aided the interpretation of muscle depth loss in our study.  
This study used ultrasound, a practical non-volitional and effect independent approach of 
monitoring muscle depth changes. Intra and interrater reliability was not performed in this 
study. However, previous work within our group showed good correlation and agreement, 
with intra- and inter-rater reliability of 0.984 and 0.965, respectively. Reliability testing was 
not performed for the MRC scoring. We recommend following a training programme with 
extensive practice to ensure competency in ultrasound and MRC score techniques, in 
addition to undertaking reliability testing.  
This study categorised patients according to their BMI; doing so relied on weight and 
heights, which in critically ill patients can be hard to accurately determine (39; 40). A variety of 
13 
 
methods were employed to get the most accurate measure possible. Experienced ICU 
dietitians were making the decisions and thus we feel confident that they are unlikely to 
place the patient in the wrong category. The limitations of BMI should also be 
acknowledged. As it is a measure of excess weight rather than excess fat, other factors such 
as age, sex, ethnicity and muscle mass can influence the BMI (41). These factors were 
considered when allocating patients to the appropriate BMI group. A patient was not 
recruited to the study if they had a raised BMI due to an increased muscle mass as opposed 
to increased adipose stores (as seen with some ethnic groups and those with increased 
musculature from excess physical training) (41).  
Recommendations for future research  
This pilot study suggests there may not be a difference in the rates of muscle wasting 
between BMI groups. It also suggests that women may lose proportionately more muscle 
mass than men, although the study was underpowered to detect a meaningful difference. 
These finding need to be confirmed in further, adequately powered studies.  
Future studies need to adjust for confounding factors such as age, gender, illness severity 
score and degree of organ failure, prior nutritional status and the adequacy of nutritional 
support received. The amount of nutrition support received (energy and protein intake) may 
influence the rate of muscle depth lost and needs to be investigated further. We 
recommend employing in-trial strategies to enhance enteral feeding delivery, such as 
reduced fasting times guidance and management of gastrointestinal intolerance. Finally, to 
ensure that functional measures of strength and recovery can be performed, patients 
should be followed up on discharge from ICU.  
To conclude, there were no differences in rates of muscle depth lost between ICU patients 
in different BMI categories in the setting of comparable nutrition support, suggesting a high 
BMI may not prevent muscle depth loss.  
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Table 1. Baseline characteristics of patients 
Characteristics  Normal  
(BMI 19-24.9)     
Overweight 
(BMI 25-29.9)      
Obese  
(BMI ≥ 30)        
Number 17 10 17 
Median (IQR) Age (years) 53(29) 65(16) 55(15) 
Gender – Male (%) 13 (77%) 6 (60%) 14 (82) 
Median (IQR) BMI  22 (4) 28 (2.5) 33 (1) 
Diagnosis: 
Surgical 
Medical  
Trauma / head injury 
 
4 
7 
6 
 
2 
5 
3 
 
4 
8 
5 
Comorbidities: 
Limited nil or 1 (%) 
Multiple >2 (%) 
 
9 (53) 
8 (47) 
 
3 (30) 
7 (70) 
 
8 (47) 
9 (53) 
Median (IQR) APACHE II score 20(7) 22(7) 20 (10) 
Median (IQR) Length of ICU stay 
(days) 
16(17) 7(6) 11(9) 
Median (IQR) Duration of mechanical 
ventilation (days) 
7(9) 4 (4) 7(10) 
% Mortality (deaths/total number) 11.7% (2/17) 40% (4/10) 35% (6/17) 
16 
 
BMI body mass index (Weight kg/height M2), IQR interquartile range, APACHE II acute 
physiology and chronic health evaluation  
No statistically significant differences between any of the groups. All P values > 0.05  
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Table 2: Measurements of muscle depth changes during critical illness 
Outcome 
 
Normal 
Weight 
(n=17) 
Overweight 
(n=10) 
Obese  
(n=17) 
Median (IQR) Initial muscle depth (cm) 8.19(2.8)* 8.90 (3.8) 11.15 (3)* 
Muscle loss as % (IQR) from initial at:  
Day 5  
Day 7  
Imputed Day 7 
Day 12 
 
10.1 (11.4) 
14.9 (19.5) 
11.6 (14.4) 
15.9 (11.8) 
 
11.0 (9) 
17.9 (19.8) 
17.9 (19.8) 
32.2 (0) 
 
8.5 (12.8) 
19.7 (18.5) 
15.6 (16.6) 
26.8 (3.6) 
Median (IQR) Muscle loss (cm) at:  
Day 5  
Day 7  
Imputed Day 7 
Day 12 
 
0.88 (1) 
1.49 (1.6) 
1.11 (1.7) 
1.44 (1.4) 
 
1.2 (0.8) 
2.08 (1.7) 
1.62 (1.5) 
4.14 (0) 
 
1.13 (1.6) 
2.39 (2.2) 
2.04 (2.2) 
2.85 (0.7) 
% loss (IQR)per day at: 
Day 5  
Day 7  
Imputed Day 7 
Day 12 
 
1.7 (1.9) 
2.5 (3.3) 
1.9 (2.4) 
2.6 (2.0) 
 
 
1.8 (1.5) 
3.0 (3.3) 
3.0 (3.3) 
5.4 (0) 
 
1.4 (2.1) 
3.3 (3.1) 
2.6 (2.7) 
4.5 (0.6) 
 
See Figure 1 for number of participants in each group at each time point.  
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Imputed day 7 – If day 7 values were missing, day 5 values were assumed to be equal and 
therefore multiple imputation applied.  
The day is the study day (not time from admission). i.e. days 5,7,12 from first data 
collection.  
*Initial muscle depth - P 0.006 between normal and obese 
For other values no statistically significant differences between any of the groups. All P 
values > 0.05 
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Table 3. Regression analysis of relationship between D7 % muscle depth loss and various 
independent variables.  
Variable Univariate  Multivariate 
Coef P values CI Coef P values CI 
Baseline BMI 
- Overweight 
- Obese 
 
0.29 
1.8 
 
0.965 
0.700 
 
-13.0 to 
13.5 
-7.7to 11.4 
 
0.29 
1.59 
 
0.96 
0.70 
 
-11.1 to 
11.7 
- 6.6 to 9.8 
Age 3.94 0.357 -4.6 to 12.5    
Gender -16.0 0.001 -25.1 to 6.9 -15.9  0.002 -25.3 to -
6.6 
Comorbidities 0.85 0.843 -9.6 to 7.89    
APACHE II  2.67 0.597 -6.4 to 10.9    
Thickest muscle depth 
D1 
0.87 0.841 -9.6 to 7.88    
Coef indicates Coefficient  
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